These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4537448)

  • 1. Relationship of the clinical course of systemic lupus erythematosus to the presence of circulating lymphocytotoxic antibodies.
    Butler WT; Sharp JT; Rossen RD; Lidsky MD; Mittal KK; Gard DA
    Arthritis Rheum; 1972; 15(3):251-8. PubMed ID: 4537448
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement.
    Bresnihan B; Oliver M; Grigor R; Hughes GR
    Clin Exp Immunol; 1977 Dec; 30(3):333-7. PubMed ID: 606449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytotoxic antibody activity in cryoprecipitates from serum of patients with SLE.
    Zvaifler NJ; Bluestein HG
    Arthritis Rheum; 1976; 19(5):844-50. PubMed ID: 1085625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating sensitized lymphocytes in systemic lupus erythematosus.
    Podleski WK; Podleski UG
    Nature; 1973 Jan; 241(5387):278-9. PubMed ID: 4633868
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus.
    Bluestein HG
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3965-9. PubMed ID: 279013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus.
    DeHoratius RJ; Messner RP
    J Clin Invest; 1975 Jun; 55(6):1254-8. PubMed ID: 1133171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes.
    Stastny P; Ziff M
    Clin Exp Immunol; 1971 Apr; 8(4):543-50. PubMed ID: 5103550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte rosette inhibition as an assay for naturally occurring T lymphocytotoxic antibody in systemic lupus erythematosus.
    Koike T; Kobayashi S; Yoshiki T; Itoh T; Shirai T
    Arthritis Rheum; 1979 Oct; 22(10):1064-73. PubMed ID: 314803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocytotoxic antibodies in systemic lupus erythematosus and clinically related diseases.
    Schocket AL; Kohler PF
    Arthritis Rheum; 1979 Oct; 22(10):1060-3. PubMed ID: 39565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current viewpoints on the pathogenesis of lupus erythematosus].
    Sönnichsen N; Haustein UF; Barthelmes H
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):581-5. PubMed ID: 4939579
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological mechanism for spontaneous abortion in systemic lupus erythematosus.
    Breshnihan B; Grigor RR; Oliver M; Lewkonia RM; Hughes GR; Lovins RE; Faulk WP
    Lancet; 1977 Dec; 2(8050):1205-7. PubMed ID: 73904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinuclear factors and human leucocytes: reaction with granulocytes and lymphocytes.
    Smalley MJ; Mackay IR; Whittingham S
    Australas Ann Med; 1968 Feb; 17(1):28-32. PubMed ID: 4871507
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct lysis of lymphocytes by complement in patients with systemic lupus erythematosus.
    Stastny P; Ziff M
    Arthritis Rheum; 1971; 14(6):733-6. PubMed ID: 5135793
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocytotoxic antibodies in patients with systemic lupus erythematosus.
    Ooi BS; Orlina AR; Pesce AJ; Mendoza N; Masaitis L; Pollak VE
    Clin Exp Immunol; 1974 Jun; 17(2):237-43. PubMed ID: 4466602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus.
    Utsinger PD
    J Rheumatol; 1976 Jun; 3(2):175-85. PubMed ID: 1084929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A depression of cell-mediated immunity to measles antigen in patients with systemic lupus erythematosus.
    Utermohlen V; Winfield JB; Zabriskie JB; Kunkel HG
    J Exp Med; 1974 Apr; 139(4):1019-24. PubMed ID: 4361242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of immunologic changes in patients with systemic lupus erythematosus].
    Huang MX
    Zhonghua Nei Ke Za Zhi; 1982 Jun; 21(6):323-6. PubMed ID: 6982154
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of IgG and IgM antinuclear antibodies in formation of lupus erythematosus cells and extracellular material.
    Blondin C; McDuffie FC
    Arthritis Rheum; 1970; 13(6):786-97. PubMed ID: 4099834
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy.
    Hill GS; Hinglais N; Tron F; Bach JF
    Am J Med; 1978 Jan; 64(1):61-79. PubMed ID: 341703
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus.
    Bluestein HG; Zvaifler NJ
    J Clin Invest; 1976 Feb; 57(2):509-16. PubMed ID: 56343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.